926 related articles for article (PubMed ID: 26756606)
1. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
2. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
[TBL] [Abstract][Full Text] [Related]
3. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
Miglioretti DL; Lange J; van den Broek JJ; Lee CI; van Ravesteyn NT; Ritley D; Kerlikowske K; Fenton JJ; Melnikow J; de Koning HJ; Hubbard RA
Ann Intern Med; 2016 Feb; 164(4):205-14. PubMed ID: 26756460
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
[TBL] [Abstract][Full Text] [Related]
5. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
van Ravesteyn NT; Miglioretti DL; Stout NK; Lee SJ; Schechter CB; Buist DS; Huang H; Heijnsdijk EA; Trentham-Dietz A; Alagoz O; Near AM; Kerlikowske K; Nelson HD; Mandelblatt JS; de Koning HJ
Ann Intern Med; 2012 May; 156(9):609-17. PubMed ID: 22547470
[TBL] [Abstract][Full Text] [Related]
6. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.
Stout NK; Lee SJ; Schechter CB; Kerlikowske K; Alagoz O; Berry D; Buist DS; Cevik M; Chisholm G; de Koning HJ; Huang H; Hubbard RA; Miglioretti DL; Munsell MF; Trentham-Dietz A; van Ravesteyn NT; Tosteson AN; Mandelblatt JS
J Natl Cancer Inst; 2014 Jun; 106(6):dju092. PubMed ID: 24872543
[TBL] [Abstract][Full Text] [Related]
7. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.
Mandelblatt JS; Cronin KA; Bailey S; Berry DA; de Koning HJ; Draisma G; Huang H; Lee SJ; Munsell M; Plevritis SK; Ravdin P; Schechter CB; Sigal B; Stoto MA; Stout NK; van Ravesteyn NT; Venier J; Zelen M; Feuer EJ;
Ann Intern Med; 2009 Nov; 151(10):738-47. PubMed ID: 19920274
[TBL] [Abstract][Full Text] [Related]
8. Benefits and Harms of Mammography Screening in 75 + Women to Inform Shared Decision-making: a Simulation Modeling Study.
Jayasekera J; Stein S; Wilson OWA; Wojcik KM; Kamil D; Røssell EL; Abraham LA; O'Meara ES; Schoenborn NL; Schechter CB; Mandelblatt JS; Schonberg MA; Stout NK
J Gen Intern Med; 2024 Feb; 39(3):428-439. PubMed ID: 38010458
[TBL] [Abstract][Full Text] [Related]
9. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Siu AL;
Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
[TBL] [Abstract][Full Text] [Related]
10. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.
van Ravesteyn NT; Stout NK; Schechter CB; Heijnsdijk EA; Alagoz O; Trentham-Dietz A; Mandelblatt JS; de Koning HJ
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25948872
[TBL] [Abstract][Full Text] [Related]
11. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
[TBL] [Abstract][Full Text] [Related]
12. Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study.
Alagoz O; Hajjar A; Chootipongchaivat S; van Ravesteyn NT; Yeh JM; Ergun MA; de Koning HJ; Chicoine B; Martin B
J Gen Intern Med; 2019 Nov; 34(11):2374-2381. PubMed ID: 31385214
[TBL] [Abstract][Full Text] [Related]
13. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
[TBL] [Abstract][Full Text] [Related]
14. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
Trentham-Dietz A; Chapman CH; Jayasekera J; Lowry KP; Heckman-Stoddard BM; Hampton JM; Caswell-Jin JL; Gangnon RE; Lu Y; Huang H; Stein S; Sun L; Gil Quessep EJ; Yang Y; Lu Y; Song J; Muñoz DF; Li Y; Kurian AW; Kerlikowske K; O'Meara ES; Sprague BL; Tosteson ANA; Feuer EJ; Berry D; Plevritis SK; Huang X; de Koning HJ; van Ravesteyn NT; Lee SJ; Alagoz O; Schechter CB; Stout NK; Miglioretti DL; Mandelblatt JS
JAMA; 2024 Apr; ():. PubMed ID: 38687505
[TBL] [Abstract][Full Text] [Related]
15. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
16. Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
Carter KJ; Castro F; Morcos RN
AJR Am J Roentgenol; 2018 Mar; 210(3):564-571. PubMed ID: 29323554
[TBL] [Abstract][Full Text] [Related]
17. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
[TBL] [Abstract][Full Text] [Related]
19. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]